The University at Buffalo School of Management will offer a new MBA concentration in biotechnology management beginning in Fall 2004. The curriculum is designed to provide a strong foundation of business principles vital to building a successful career in the biotechnology field.
The University at Buffalo School of Nursing will inaugurate a new program in January to prepare nurses to be psychiatric/mental health nurse practitioners, one of the most in-demand and financially rewarding of nursing specialties.
Is exercise good or bad for cancer survivors? Should they eat hearty or restrict calories to speed recovery and prevent recurrence? Is a glass of wine a bad thing? A UB nursing professor headed a panel established by the American Cancer Society to answer these and many other questions concerning what persons who have survived cancer can do to lower their risk of recurrence and how those living with cancer can experience life to the fullest.
Researchers from the University at Buffalo have developed a virtual-reality driving simulator that may help car-accident survivors recover from post-traumatic stress disorder (PTSD) -- a prevalent, but commonly untreated, condition associated with serious car accidents.
A new documentary by Danish director and filmmaker Anne-Gyrithe Bonne, "The Will to Live: A Notebook on Love, Hate and Reconciliation," will be presented, along with one of its subjects, Cambodian-American writer Chanrithy Him, on Nov. 20 at the University at Buffalo.
Four University at Buffalo faculty members recently were honored by the State University of New York for significant accomplishments in their respective academic fields.
University at Buffalo researchers using the latest computer-assisted technologies of genetic analysis have shown for the first time how a widely used drug for treating multiple sclerosis -- interferon beta (IFN-beta-1a) -- can modulate the expression of particular genes in patients being treated for the disease.
Researchers at the University at Buffalo's Research Institute on Addictions are developing a hybrid treatment method that incorporates training for parents, couples therapy and reduction of substance abuse as a means to improve the behavior and functioning of children of substance-abusing parents.
In a classic example of scientific research that has successfully outgrown the university lab where it was born, a University at Buffalo professor's unique method for designing and synthesizing anti-cancer compounds, called protein kinase inhibitors, is being commercialized.
A joint project between the University at Buffalo's Research Institute on Addictions and the Jellinek Clinic in Amsterdam, the Netherlands, will examine how behavioral couples therapy works for cocaine-abusing patients across cultures.